Patient Data – the unique role in Cell and Gene Therapies (CGTs)
Patient and/or donor data is an essential part of manufacturing and delivery, in unique and complex ways. It is also fundamental to patient safety and product and process knowledge, providing the opportunity to reduce risk and accelerate development.
This paper will explore how the CGT supply chain is different from that of traditional drug products, why patient data is critical, how patient data is used, and why integrated systems are key to the sector’s future success.
- Patient data is mission-critical data — especially in cell and gene therapy.
- Patient data – why it is critical for cell and gene therapy stakeholders
- Patient data – unique challenges, critical uses in the cell therapy value chain
- Integrated patient data – the future of advanced therapies